Steven R Little

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Are you Steven R Little?

Claim your profile

Publications (79)363.3 Total impact

  • Timothy D Knab, Steven R Little, Robert S Parker
    [Show abstract] [Hide abstract]
    ABSTRACT: Mathematical models of controlled release that span the in vitro to in vivo transition are needed to speed the development and translation of clinically-relevant controlled release drug delivery systems. Fully mechanistic approaches are often challenged due to the use of highly-parameterized mathematically complex structures to capture the release mechanism. The simultaneous scarcity of in vivo data to inform these models and parameters leads to a situation where overfitting to capture observed phenomena is common. A data-driven approach to model development for controlled drug release from polymeric microspheres is taken herein, where physiological mechanisms impacting controlled release are incorporated to capture observed changes between in vitro release profiles and in vivo device dynamics. The model is generalizable, using non-specific binding to capture drug-polymer interactions via charge and molecular structure, and it has the ability to describe both inhibited (slowed) and accelerated release resulting from electrostatic or steric interactions. Reactive oxygen species (ROS)-induced degradation of biodegradable polymers was incorporated via a reaction-diffusion formalism, and this suggests that ROS may be the primary effector of the oft-observed accelerated in vivo release of polymeric drug delivery systems. Model performance is assessed through comparisons between model predictions and controlled release of several drugs from various-sized microparticles in vitro and in vivo. Copyright © 2015. Published by Elsevier B.V.
    Journal of Controlled Release 05/2015; DOI:10.1016/j.jconrel.2015.04.045 · 7.26 Impact Factor
  • James D. Fisher, Abhinav P. Acharya, Steven R. Little
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite decades of advances in transplant immunology, tissue damage caused by acute allograft rejection remains the primary cause of morbidity and mortality in the transplant recipient. Moreover, the long-term sequelae of lifelong immunosuppression leaves patients at risk for developing a host of other deleterious conditions. Controlled drug delivery using micro- and nanoparticles (MNPs) is an effective way to deliver higher local doses of a given drug to specific tissues and cells while mitigating systemic effects. Herein, we review several descriptions of MNP immunotherapies aimed at prolonging allograft survival. We also discuss developments in the field of biomimetic drug delivery that use MNP constructs to induce and recruit our bodies' own suppressive immune cells. Finally, we comment on the regulatory pathway associated with these drug delivery systems. Collectively, it is our hope the studies described in this review will help to usher in a new era of immunotherapy in organ transplantation. Copyright © 2015. Published by Elsevier Inc.
    Clinical Immunology 05/2015; DOI:10.1016/j.clim.2015.04.013 · 3.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Colloidal crystals are interesting materials owing to their customizable photonic properties, high surface area, and analogy to chemical structures. The flexibility of these materials has been greatly enhanced through mixing particles with varying sizes, compositions, and surface charges. In this way, distinctive patterns or analogies to chemical stoichiometries are produced; however, to date, this body of research is limited to particles with nanoscale dimensions. A simple method is now presented for bottom-up assembly of non-Brownian particle mixtures to create a new class of hierarchically-ordered materials that mimic those found in nature (both in pore distribution as well as stoichiometry). Additionally, these crystals serve as a template to create particle-based inverted crystalline structures with customizable properties. © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
    Angewandte Chemie International Edition 04/2015; 54(20). DOI:10.1002/anie.201500273 · 11.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Inflammatory bone resorption is a hallmark of periodontitis, being Treg and Th2 cells independently associated with disease progression attenuation. In this study, we employed an infection-triggered inflammatory osteolysis model to investigate the mechanisms underlying Treg and Th2 cell migration and impact on disease outcome. A. actinomycetemcomitans-infected C57Bl/6 (WT) mice develop an intense inflammatory reaction and alveolar bone resorption, being Tregs of Th2 cells migration temporally associated with disease progression attenuation. Tregs extracted from the lesions preferentially express CCR4 and CCR8, while Th2 cells express CCR3, CCR4 and CCR8. The absence of CCR5 and CCR8 did not impact Th2 and Tregs migration or disease outcome in a significant manner. CCR4KO mice presented a minor reduction in Th2 in parallel with major impairment of Tregs migration, associated with increased inflammatory bone loss and higher pro-inflammatory and osteoclastogenic cytokines levels. The blockade of the CCR4 ligand CCL22 in WT mice resulted in increased inflammatory bone loss phenotype similarly to CCR4KO strain. Adoptive transfer of CCR4+Tregs to CCR4KO strain revert the increased disease phenotype to WT mice-like levels, being the production of CCL22 in the lesions mandatory for Tregs migration and the consequent bone loss arrest. The local release of exogenous CCL22 provided by PLGA-microparticles promote Tregs migration and disease arrest in the absence of endogenous CCL22 IL-4KO strain, characterized by the lack of endogenous CCL22 production, defective Tregs migration and exacerbated bone loss. In summary, our results demonstrate that the involvement of IL-4/CCL22/CCR4 axis in the migration of Tregs to osteolytic lesions sites, and attenuates development of lesions by inhibiting inflammatory migration and the production of pro-inflammatory and osteoclastogenic mediators. © 2014 American Society for Bone and Mineral Research
    Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 03/2015; 30(3):400-10. DOI:10.1002/jbmr.2376 · 6.59 Impact Factor
  • Melissa H. Lash, Morgan Fedorchak, Steven R. Little
    [Show abstract] [Hide abstract]
    ABSTRACT: Particle-based crystals have been explored as a basis for creating ordered porous materials for applications in molecular electronics, photonics, sensors, and drug delivery. However, much of the research on these crystals has been focused on particles of nano and sub-micron dimensions (so-called colloidal crystals) with limited attention directed towards building blocks with dimensions ranging from tens to hundreds of microns. Larger (particle) components, however, offer many practical benefits ranging from a mass transfer as well as mechanical strength perspective and often involve easier synthesis of materials, easier yet potentially more sophisticated surface functionality, simpler measurements of the assembly process, and greater control of the interaction strength and selectivity. Despite these advantages, self-assembly at larger scales remains in its infancy. Components on the meso- and macro-scales are generally influenced by forces within the system in a different manner than their nano-scale counterparts; the underlying thermal effects in these larger systems typically cannot naturally overcome kinetic barriers generally leading to the components becoming kinetically arrested in non-equilibrium states. In this work, we introduce ultrasonic agitation into a system of large particles (or mixtures of particles) and explore the impact that external agitation at varying input energies has on the packing behavior of both monodispersed microparticle populations as well as mixtures of microparticles. Additionally, we will examine the implications of this work on the resulting mechanical properties of “large particle”-based crystals (both monodisperse and mixed-size). The implications of this work will hopefully lead to a better understanding of the assembly behavior and resulting mechanical properties of “large particle”-based crystals.
    14 AIChE Annual Meeting; 11/2014
  • Melissa H. Lash, Morgan Fedorchak, Steven R. Little
    [Show abstract] [Hide abstract]
    ABSTRACT: Hierarchically ordered porous materials hold promise for enhanced performance in a variety of fields. Specifically, in terms of a hierarchical pore structure (ranging from the nano-micron size regimes) many practical advantages can be derived from having a high surface area and pore volume, as well as providing size selectivity for molecule/particle diffusion and substantial interfacial area. An exceptionally promising technique for the formation of ordered porous materials is the use of colloidal crystal templating, with much attention paid to nano-scale self-assembly. Larger (micron-scale particle) components, however, offer benefits from a mass transfer as well as mechanical strength perspective and often involve easier synthesis of materials, easier yet potentially more sophisticated surface functionality, simpler measurements of the assembly process, and greater control of the interaction strength and selectivity. Despite these advantages, self-assembly at larger scales remains in its infancy. Larger components become more readily arrested in a non-equilibrium configuration (compared to nano-scale counterparts) as these larger systems are less influenced by the underlying thermal effects. This tendency for kinetic arrest limits the translation of nano-scale assembly techniques up to larger component scales. In this work, ultrasonic agitation is explored as a means of allowing large microparticles (18-750m) to overcome kinetic barriers to packing in the creation of close-packed, highly ordered, crystalline structures. Specifically, the relationship between particle packing behavior and energy input is being characterized in terms of crystallinity. Additionally, we have extended this technique for crystal fabrication to create multi-component crystals made from two or more particle sizes. When we combine these "large-particle" assembly techniques with traditional nano-scale colloidal crystallization an exciting opportunity arises to tailor the mechanical and surface properties as well as the pore size of the resulting hierarchically structured materials.
    14 AIChE Annual Meeting; 11/2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Disease and injury perturb the balance of processes associated with inflammation and tissue remodeling, resulting in positive feedback loops, exacerbation of disease and compromised tissue repair. Conversely, under homeostatic healthy conditions, these processes are tightly regulated through the expansion and/or recruitment of specific cell populations, promoting a balanced steady-state. Better understanding of these regulatory processes and recent advances in biomaterials and biotechnology have prompted strategies to utilize cells for the treatment and prevention of disease through regulation of inflammation and promotion of tissue repair. Herein, we describe how cells that regulate these processes can be increased in prevalence at a site of disease or injury. We review several relevant cell therapy approaches as well as new strategies for directing endogenous regulatory cells capable of promoting environmental homeostasis and even the establishment of a pro-regenerative micro-environment. Collectively, these examples may provide a blueprint for next-generation "medicine" that spurs the body's own cells to action and replaces conventional drugs.
    Annals of Biomedical Engineering 09/2014; 43(3). DOI:10.1007/s10439-014-1125-2 · 3.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The ability to deliver but hide immunogenic payloads and then reveal them at predetermined times could lead to autonomously boosting vaccine formulations or improved antigen–adjuvant vaccine designs. We used in silico modeling to determine the appropriate formulation and material properties for poly(lactic-co-glycolic) acid (PLGA) microparticles such that they would delay the in vitro “unmasking” of an ovalbumin-alum payload for precise and predetermined intervals. A preferred formulation was then tested in vivo. In vivo T cell proliferation data confirmed the presentation of antigen released through the programmed delayed burst while antibody subclass data demonstrated immunogenicity comparable to that observed with established multiple injection prime-boost regimens.
    08/2014; 2(37). DOI:10.1039/C4TB01042F
  • G P Garlet, C S Sfeir, S R Little
    [Show abstract] [Hide abstract]
    ABSTRACT: The disruption of host-microbe homeostasis at the site of periodontal disease is considered a key factor for disease initiation and progress. While the downstream mechanisms responsible for the tissue damage per se are relatively well-known (involving various patterns of immune response operating toward periodontal tissue destruction), we are only beginning to understand the complexity of host-microbe interactions in the periodontal environment. Unfortunately, most of the research has been focused on the disruption of host-microbe homeostasis instead of focusing on the factors responsible for maintaining homeostasis. In this context, regulatory T-cells (Tregs) comprise a CD4+FOXp3 +T-cell subset with a unique ability to regulate other leukocyte functions to avoid excessive immune activation and its pathological consequences. Tregs act as critical determinants of host-microbe homeostasis, as well as determinants of a balanced host response after the disruption of host-microbe homeostasis by pathogens. In periodontitis, Tregs play a protective role, with their natural recruitment being responsible for conversion of active into inactive lesions. With controlled-release technology, it is now possible to achieve a selective chemoattraction of Tregs to periodontal tissues, attenuating experimental periodontitis evolution due to the local control of inflammatory immune response and the generation of a pro-reparative environment.
    Journal of Dental Research 07/2014; 93(9). DOI:10.1177/0022034514544300 · 4.14 Impact Factor
  • Hui-Li Fu, Yi Hong, Steven R Little, William R Wagner
    [Show abstract] [Hide abstract]
    ABSTRACT: As a means to stimulate wound healing, a hollow fiber membrane system might be placed within a wound bed to provide local and externally regulated controlled delivery of regenerative factors. After sufficient healing, it would be desirable to triggerably degrade these fibers as opposed to pulling them out. Accordingly, a series of enzymatically degradable thermoplastic elastomers was developed as potential hollow fiber base material. Polyurethane ureas (PUUs) were synthesized based on 1, 4-diisocyanatobutane, polycaprolactone (PCL) diol and polyethylene glycol (PEG) at different molar fractions as soft segments, and collagenase-sensitive peptide GGGLGPAGGK-NH2 as a chain extender (defined as PUU-CLxEGy-peptide, where x and y are the respective molar percents). In these polymers, PEG in the polymer backbone decreased tensile strengths and initial moduli of solvent-cast films in the wet state, while increasing water absorption. Collagenase degradation was observed at 75% relative PEG content in the soft segment. Control PUUs with putrescine or nonsense peptide chain extenders did not degrade acutely in collagenase. Conduits electrospun from PUU-CL25EG75-peptide and PUU-CL50EG50-peptide exhibited appropriate mechanical strength and sustained release of a model protein from the tube lumen for 7 d. Collapse of PUU-CL25EG75-peptide tubes occurred after collagenase degradation for 3 d. In conclusion, through molecular design, synthesis and characterization, a collagenase-labile PUU-CL25EG75-peptide polymer was identified that exhibited the desired traits of triggerable lability, processability, and the capacity to act as a membrane to facilitate controlled protein release.
    Biomacromolecules 07/2014; 15(8). DOI:10.1021/bm500552f · 5.79 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Colloidal crystals have been explored in the literature for applications in molecular electronics, photonics, sensors, and drug delivery. However, much of the research on colloidal crystals has been focused on nano-sized particles with limited attention directed towards building blocks with dimensions ranging from tens to hundreds of microns. This can be attributed, in part, to the fact that particles with greater than sub-micron dimensions do not naturally assemble in an organized fashion due to the relatively miniscule influence of thermalizing forces. Nevertheless, ordered arrays of large, micron-scale particles are of interest as a basis for the production of hierarchically structured materials with customizable pore sizes. In this work, ultrasonic agitation is being explored as a means of allowing large, non-Brownian microparticles (18-750µm) to overcome kinetic barriers to packing in the creation of close packed, highly ordered, crystalline structures. In addition we study how the energy input affects bulk particle behavior and describe several new ways to characterize colloidal crystals made from microparticles.
    Langmuir 07/2014; 31(3). DOI:10.1021/la501511s · 4.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Treatment of glaucoma by intraocular pressure (IOP) reduction is typically accomplished through the administration of eye drops, the difficult and frequent nature of which contributes to extremely low adherence rates. Poor adherence to topical treatment regimens in glaucoma patients can lead to irreversible vision loss and increased treatment costs. Currently there are no approved treatments for glaucoma that address the inherent inefficiences in drug delivery and patient adherence. Brimonidine tartrate (BT), a common glaucoma medication, requires dosing every 8-12 hours, with up to 97% of patients not taking it as prescribed. This study provides proof-of-principle testing of a controlled release BT formulation. BT was encapsulated in poly(lactic-co-glycolic) acid microspheres and drug release was quantified using UV-Vis spectroscopy. For in vivo studies, rabbits were randomized to receive a single subconjunctival injection of blank (no drug) or BT-loaded microspheres or twice daily topical 0.2% BT drops. The microspheres released an average of 2.1±0.37 μg BT/mg microspheres/day in vitro. In vivo, the percent decrease in IOP from baseline was significantly greater in the treated eye for both topical drug and drug-loaded microspheres versus blank microspheres throughout the 4-week study, with no evidence of migration or foreign body response. IOP measurements in the contralateral, untreated eyes also suggested a highly localized effect from the experimental treatment. A treatment designed using the release systems described in this study would represent a vast improvement over the current clincial standard of 56-84 topical doses over 28 days.
    Experimental Eye Research 06/2014; 125. DOI:10.1016/j.exer.2014.06.013 · 3.02 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although approved by the United States Food and Drug Administration, enfuvirtide is rarely used in combination antiretroviral therapies (cART) to treat HIV-1 infection, primarily because of its intense dosing schedule that requires twice daily subcutaneous injection. Here, we describe the development of enfuvirtide-loaded, degradable poly(lactic-co-glycolic) acid microparticles that provide linear in vitro release of the drug over an 18 day period. This sustained release formulation could make enfuvirtide more attractive for use in cART.
    Antimicrobial Agents and Chemotherapy 12/2013; 58(3). DOI:10.1128/AAC.02440-13 · 4.45 Impact Factor
  • Melissa H. Lash, Steven R. Little
    [Show abstract] [Hide abstract]
    ABSTRACT: Colloidal crystals have been explored in the literature for applications in molecular electronics, photonics, sensors, and drug delivery. However, much of the research on colloidal crystals has been focused on nano-sized particles with limited attention directed towards building blocks with dimensions ranging from tens to hundreds of microns. This can be attributed, in part, to the fact that large-scale particles are less prone to assemble in an organized fashion due to the relative absence of thermalizing forces. Nevertheless, ordered arrays of large particles are of interest both as a basis for the production of hierarchically structured materials as well as for tissue engineering scaffolds due to large pore sizes. In this work, ultrasonic agitation is being explored as a means of artificially “thermalizing” these particles in order to overcome kinetic barriers to packing in the creation of close packed, highly ordered, crystalline structures from large microparticles (18-750um). Using this process, we have been able to create and characterize both two- and three-dimensional structures by adjusting properties of the system and observing the changes using a variety of microscopy techniques. We are currently investigating the significance of various substrate and solution properties such as surface tension, viscosity, particle concentration and particle composition both experimentally and computationally. The interactions between the constituent particles within these colloidal formations can be estimated and analyzed, ideally providing insight into, and control over the formation of desired crystal structures.
    13 AIChE Annual Meeting; 11/2013
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The hallmark of periodontal disease is the progressive destruction of gingival soft tissue and alveolar bone, which is initiated by inflammation in response to an invasive and persistent bacterial insult. In recent years, it has become apparent that this tissue destruction is associated with a decrease in local regulatory processes, including a decrease of forkhead box P3-expressing regulatory lymphocytes. Accordingly, we developed a controlled release system capable of generating a steady release of a known chemoattractant for regulatory lymphocytes, C-C motif chemokine ligand 22 (CCL22), composed of a degradable polymer with a proven track record of clinical translation, poly(lactic-co-glycolic) acid. We have previously shown that this sustained presentation of CCL22 from a point source effectively recruits regulatory T cells (Tregs) to the site of injection. Following administration of the Treg-recruiting formulation to the gingivae in murine experimental periodontitis, we observed increases in hallmark Treg-associated anti-inflammatory molecules, a decrease of proinflammatory cytokines, and a marked reduction in alveolar bone resorption. Furthermore, application of the Treg-recruiting formulation (fabricated with human CCL22) in ligature-induced periodontitis in beagle dogs leads to reduced clinical measures of inflammation and less alveolar bone loss under severe inflammatory conditions in the presence of a diverse periodontopathogen milieu.
    Proceedings of the National Academy of Sciences 10/2013; DOI:10.1073/pnas.1302829110 · 9.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The shorter, the more dispersible: An iterative, emulsion-based shortening technique has been used to reduce the length of single-walled carbon nanotubes (SWNTs) to the same order of magnitude as their diameter (ca. 1 nm), thus achieving an effectively "zero-dimensional" structure with improved dispersibility and, after hydroxylation, long-term water solubility. Finally, zero-dimensional SWNTs were positively identified using mass spectrometry for the first time.
    Angewandte Chemie International Edition 10/2013; 52(43). DOI:10.1002/anie.201305526 · 11.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Je kürzer, desto dispergierbarer: Mit einer iterativen Emulsionsmethode wurde die Länge von einwandigen Kohlenstoffnanoröhren (SWNTs) auf die Größenordnung ihres Durchmessers (ca. 1 nm) reduziert, um ,,nulldimensionale“ Strukturen mit verbesserter Dispergierbarkeit und, nach einer zusätzlichen Hydroxylierung, mit langfristiger Löslichkeit in Wasser zu erhalten. Zudem konnten nulldimensionale SWNTs erstmalig massenspektrometrisch nachgewiesen werden.
    Angewandte Chemie 10/2013; 125(43). DOI:10.1002/ange.201305526
  • [Show abstract] [Hide abstract]
    ABSTRACT: Glaucoma is the second leading cause of blindness in the United States. Brimonidine tartrate (BT) is a modern anti-glaucoma agent that is currently administered as frequently as a thrice-daily topical eye drop medication. Accordingly, compliance with BT regimens is low, limiting overall effectiveness. One attempt that has previously proven effective to address non-adherence is the formation of ocular inserts, such as the Ocusert ®, whose diffusion based control released an older drug (pilocarpine) for a week-long period. Modern controlled drug release technology provides an avenue for extending the release of practically any drug (including new drugs like BT) for as long as one month from a singular insert. Currently, no controlled release formulations for BT exist. This work outlines the development and characterization of a BT releasing ocular insert designed from poly (lactic co-glycolic) acid (PLGA)/poly ethylene glycol (PEG). We found that a formulation containing 15% PEG can be created that produces a linear BT release profile corresponding to BT eye drop delivery estimates. Additionally, these inserts were shown, through the use of atomic force microscopy and scanning electron microscopy, to have smooth surfaces and physical properties suitable for ophthalmic use.
    Acta biomaterialia 09/2013; 10(1). DOI:10.1016/j.actbio.2013.09.024 · 5.68 Impact Factor
  • Angewandte Chemie International Edition 09/2013; · 11.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Tregs play important roles in maintaining immune homeostasis, and thus, therapies based on Treg are promising candidates for the treatment for a variety of immune-mediated disorders. These therapies, however, face the significant challenge of obtaining adequate numbers of Tregs from peripheral blood that maintains suppressive function following extensive expansion. Inducing Tregs from non-Tregs offers a viable alternative. Different methods to induce Tregs have been proposed and involve mainly treating cells with TGF-β-iTreg. However, use of TGF-β alone is not sufficient to induce stable Tregs. ATRA or rapa has been shown to synergize with TGF-β to induce stable Tregs. Whereas TGF-β plus RA-iTregs have been well-described in the literature, the phenotype, function, and migratory characteristics of TGF-β plus rapa-iTreg have yet to be elucidated. Herein, we describe the phenotype and function of mouse rapa-iTreg and reveal that these cells differ in their in vivo homing capacity when compared with mouse RA-iTreg and mouse TGF-β-iTreg. This difference in migratory activity significantly affects the therapeutic capacity of each subset in a mouse model of colitis. We also describe the characteristics of iTreg generated in the presence of TGF-β, RA, and rapa.
    Journal of leukocyte biology 07/2013; 94(5). DOI:10.1189/jlb.0312167 · 4.99 Impact Factor

Publication Stats

1k Citations
363.30 Total Impact Points

Institutions

  • 2006–2015
    • University of Pittsburgh
      • • Chemical and Petroleum Engineering
      • • Department of Ophthalmology
      • • Bioengineering
      • • McGowan Institute for Regenerative Medicine
      • • Department of Immunology
      Pittsburgh, Pennsylvania, United States
  • 2004–2010
    • Massachusetts Institute of Technology
      • Department of Chemical Engineering
      Cambridge, Massachusetts, United States